{"result": {"id": "chatcmpl-807", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Retinal Health Research Community\",\n    \"summary\": \"This report analyzes a community focused on retinal health research, exploring its key entities and their interrelationships. The community comprises researchers, clinicians, and patients working to understand and treat eye diseases like age-related macular degeneration (AMD).  The report highlights the impact of specific entities on the community's progress in developing treatments for AMD.\",\n    \"rating\": 8.0,\n    \"rating_explanation\": \"This community has a significant impact due to its focus on a serious and prevalent disease affecting millions globally. The research conducted here directly contributes to improving patient outcomes and potentially finding cures for AMD.\",\n    \"findings\": [\n        {\n            \"summary\": \"Age-related macular degeneration (AMD) is a leading cause of vision loss, and this community plays a crucial role in developing treatments for it.\",\n            \"explanation\": \"The community's focus on AMD research is evident through the numerous references to its impact.  For example, researchers are actively investigating new therapies like gene therapy and stem cell transplantation to address the underlying causes of AMD. The community also focuses on understanding the disease progression and identifying biomarkers for early diagnosis. This work contributes significantly to developing effective treatments and ultimately improving patient outcomes.\"\n        },\n        {\n            \"summary\": \"The community's research is driven by a strong network of researchers, clinicians, and patients.\",\n            \"explanation\": \"This community thrives on collaboration. Researchers share their findings through publications, conferences, and collaborations with other institutions. Clinicians provide valuable insights from patient care and clinical trials. Patients contribute to the research process by participating in studies and sharing their experiences. This collaborative approach fosters innovation and accelerates progress towards finding effective treatments for AMD.\"\n        },\n        {\n            \"summary\": \"The community's work is supported by funding from various sources, including government agencies, foundations, and private investors.\",\n            \"explanation\": \"Funding is essential to support research efforts in this field.  Government agencies like the National Institutes of Health (NIH) provide grants for research projects focused on AMD. Foundations dedicated to eye health also contribute funding. Private investors are increasingly interested in supporting innovative treatments for AMD, recognizing its significant impact on patients and society.\"\n        },\n        {\n            \"summary\": \"The community's progress is measured through clinical trials, publications, and the development of new therapies.\",\n            \"explanation\": \"Clinical trials are essential to evaluate the safety and efficacy of new treatments.  Published research findings provide valuable insights into the disease process and potential treatment strategies. The development of new therapies represents a significant milestone in the community's progress towards finding effective solutions for AMD.\"\n        },\n        {\n            \"summary\": \"The community is actively engaged in patient advocacy and education.\",\n            \"explanation\": \"Patient advocacy groups play a vital role in raising awareness about AMD, advocating for research funding, and providing support to patients.  Education initiatives empower individuals with knowledge about the disease, its symptoms, and available treatment options.\"\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743257003, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 640, "prompt_tokens": 2048, "total_tokens": 2688, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n1624,INTRAVITREAL INJECTION,,6\n16,CHOROIDAL NEOVASCULARIZATION,\"**Choroidal neovascularization (CNV)** is a condition affecting the **eye**, characterized by leakage of blood vessels in the **choroid**. This can lead to central vision loss and threaten overall vision.  It is often associated with age-related macular degeneration (AMD) and studied as a target for research. \n\",18\n20,HUMAN CHORODIAL VASCULAR ENDOTHELIAL CELLS,Cells used for studying CNV,6\n3542,HONOKIOL,Honokiol is a lignan isolated from Magnolia officinalis and exhibits anti-angiogenic properties,6\n19,MALAT1,\"The **MALAT1** gene is a long non-coding RNA (lncRNA) that plays a significant role in various biological processes. It is known to be upregulated in multiple myeloma, the retinal pigment epithelial-choroidal complexes, and age-related macular degeneration.  This gene is also involved in regulating gene expression by interacting with other molecules. \n\",5\n11,ARPE-19,\"The **ARPE-19** cell line is a widely used model in research, particularly for studying the development of **choroidal neovascularization (CNV)**. It is also employed to investigate the effects of **hypoxia** and the role of **VEGFA** expression.  This cell line can be utilized to derive conditioned medium, which provides a valuable tool for understanding cellular interactions and signaling pathways relevant to various ocular diseases. \n\",5\n3546,TRANSWELL AND TUBE FORMATION ASSAYS,,2\n404,CHROMATIN IMMUNOPRECIPITATION,Chromatin immunoprecipitation assay used to study gene regulation,2\n1320,LASER PHOTOCOAGULATION,Procedure used to treat CNV lesions,1\n3547,HEMATOXYLIN AND EOSIN STAINING,,1\n3549,LUCIFERASE ASSAY,,1\n3550,FUNDUS FLUORESCEIN ANGEIOGRAPHY,\"\nA technique used to visualize blood vessels in the eye\",1\n3552,MECHANISM STUDIES,\"\nStudies that investigate how honokiol works)<|COMPLETE|> Please provide me with the following information so I can help you with this task:1. **The previous extraction results:**  Share the list of entities and relationships that were extracted in your last attempt. This will give me context about what types you're looking for. 2. **The text you want to extract entities from:** Paste the text you want to analyze. Once I have this information, I can help you identify and extract relevant entities based on your previously defined types.\",1\n1908,MACULAR DEGENERATION,AMD is a disease of the macula,4\n536,AGE-RELATED MACULAR DEGENERATION,\"**Age-related macular degeneration (AMD)** is a common eye disease that causes vision loss. It is a leading cause of vision loss in the elderly and a common cause of blindness in this population.  AMD's main pathological change involves damage to the macula, the central part of the retina responsible for sharp, detailed vision. While AMD can be rare, it is often considered a significant eye disease. \n\",8\n2142,POLYPOIDAL CHORODIAL VASCUOPATHY,A condition that can cause vision loss,3\n1791,PM-CNV,\"The **PM-CNV** is a condition that was studied in a retrospective study and is also a specific type of eye condition. \n\",3\n1534,EXUDATIVE AMD,\"The **EXUDATIVE AMD** is a type of age-related macular degeneration (AMD) characterized by severe vision loss. It is a focus of research, particularly in relation to anti-VEGF therapy, and is studied as an eye disease that can lead to significant visual impairment.  \n\",1\n1794,1+PRN,Group of patients with one PRN,4\n1795,3+PRN,Group of patients with three PRNs,4\n1066,CRT,\"The **CRT** is a measure of the severity of a disease, and it can also be used as another medical test to measure the effectiveness of a treatment.  Specifically, CRT refers to Central Retinal Thickness (CRT) measurements. \n\",4\n1793,BCVA,\"The **BCVA** (Best Corrected Visual Acuity) is a measurement of visual acuity that assesses the severity of vision loss. It is used to determine the effectiveness of treatments for vision problems.  BCVA is typically measured at different points in time, such as month 3, and it represents the best possible vision after correcting for refractive errors using eyeglasses or contact lenses.  \n\",4\n3555,HYPOXIA-INDUCIBLE FACTOR-1Α/VASCULAR ENDOTHELIAL GROWTH FACTOR AXIS,,3\n3556,\"PROLIFERATION, MIGRATION, AND TUBE FORMATION\",,3\n1881,ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR,\"The **anti-vascular endothelial growth factor (anti-VEGF)** drugs are used to treat age-related macular degeneration (AMD) and central serous retinopathy (CNV). These medications are specifically designed to inhibit the action of VEGF, a protein that plays a crucial role in the development of blood vessels.  They are effective treatments for CNV, which is characterized by abnormal fluid buildup under the retina. \n\",2\n1782,CONBERCEPT,\"**CONBERCEPT** is a medication currently under investigation for its clinical efficacy in treating **PM-CNV**. It is being tested as a potential treatment option for this condition.  Conbercept has also been used to treat **PM-CNV**, and it is specifically designed to address **choroidal neovascularization secondary to pathological myopia**. \n\",3\n1907,NONEXUDATIVE MACULAR NEOVASCULARIZATION,Nonexudative MNV is a condition that occurs in AMD,3\n3103,SULT2B1,Enzyme involved in sterol sulfonation and inflammation,3\n3548,IMMUNOFLOORESCENCE,,1\n3545,5-ETHYNYL-20-DEOXYURIDINE ASSAY,,1\n3551,20MG/KG,,1\n22,HCVECS,,1\n1798,MICRORNA-15A/16,,1\n3554,RETINAL PIGMENTED EPITHELIAL CELLS,Cells that produce a medium used in research,3\n5359,MACULAR ATROPHY,A condition affecting vision,1\n5360,54-YEAR-OLD WOMAN,A woman who is 54 years old,5\n5361,BRUCH MEMBRANE RUPTURE,\"A rupture of the Bruch membrane, a layer in the eye\",1\n5362,ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR DRUG,A drug used to treat macular atrophy,1\n1910,EXUDATIVE PROGRESSION,,2\n176,MYOPIC CHOROIDAL NEOVASCULARIZATION,Myopic condition causing macular haemorrhages,2\n2290,ANIMAL MODEL,\"The **Animal Model** is a tool used in research, specifically for studying microchromosome numerical variations (mCNVs).  It serves as a platform for investigating these genetic changes. \n\",3\n365,VISION LOSS,\"**Vision loss**, also known as **loss of sight**, is a significant condition characterized by a decrease in visual acuity. It can be caused by various factors, including myopic choroidal neovascularization (mCNV), a major cause of vision loss.  This condition can manifest as a sudden onset of diminished vision in the right eye (OS) over a one-week period. Vision loss is often associated with age-related macular degeneration (AMD). \n\",3\n2291,GENE,Genes associated with mCNV,2\n2292,PATHWAY,Pathways associated with mCNV,2\n3537,BASELINE,,1\n3538,FOLLOW-UP,,1\n4338,ENDOMETRAL-MESENCHYMAL TRANSITION,Cellular process that can contribute to renal fibrosis,2\n253,VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF),\"The **Vascular Endothelial Growth Factor (VEGF)** is a protein that plays a crucial role in various biological processes, including blood vessel formation and development. It is involved in the creation of new blood vessels, known as angiogenesis, which is essential for tissue growth and repair.  \n\nHowever, VEGF also has a significant impact on pathological conditions. In tumorigenesis, it promotes the growth of tumors by stimulating angiogenesis. Additionally, VEGF plays a role in neovascular eye diseases like age-related macular degeneration (AMD). \n\nFurthermore, VEGF is implicated in kidney fibrosis, where its activity contributes to the development of scar tissue and impaired kidney function.  \n\",3\n4995,STABLE GROUP,\"The **STABLE GROUP** consists of patients with stable choroidal neovascularization, characterized by eyes that have received a maximum of two injections within the past year.  \n\",3\n4997,LEION AREA,,2\n4998,JUNCTION DENSITY,,2\n4996,UNSTABLE GROUP,\"The **UNSTABLE GROUP** consists of patients who have experienced multiple intraocular injections within a one-year period, specifically those exhibiting unstable choroidal neovascularization.  This indicates a group of individuals facing challenges related to the stability and progression of their condition. \n\",3\n252,RETINAL PIGMENTED EPITHELIUM (RPE),Cells in the retina that are involved in vision,1\n1909,TREATMENT-NAIVE NONEXUDATIVE MNV,,1\n2143,INDOCYANINE GREEN ANGIOLOGY,A technique used to visualize blood vessels in the eye,1\n2144,CONFLECT SCANNING LASER OPHTHALMOSCOPY,A technique used to visualize the retina,1\n2873,3K3A-APC,,3\n149,MOUSE MODEL,\"The **MOUSE MODEL** is a versatile tool used in various research areas. It serves as an animal model to investigate diverse biological phenomena, including the effects of specific drugs and treatments on various physiological processes.  \n\nSome notable applications include studying the impact of honokiol on choroidal neovascularization, investigating dapagliflozin's effect on limb ischemia, and examining placental development in mice. The **MOUSE MODEL** is also employed to study gastric cancer using genetic modifications, explore the effects of AAV8 vector on CNV, and investigate the consequences of oxygen-induced retinopathy.  \n\nFurthermore, certain **MOUSE MODELS** are specifically designed for studying tumor growth, such as those used in xenograft studies with subcutaneously injected pancreatic ductal adenocarcinoma (PDAC) cells. \n\n\n\",1\n1783,CHOROIDAL NECROPSY,\"The **choroidal necropsies** are a study area for investigating age-dependent anti-angiogenic capability of melatonin.  Specifically, they focus on the **AMD condition**, which affects the **choroid** (the layer of tissue beneath the retina). This condition is also known as **choroidal neovascularization (CNV)** and can be studied in relation to its impact on the eye's health. \n\",1\n3534,20/50 SNELLEN EQUIVALENT,A measurement of visual acuity,2\n3539,ACTIVE LESIONS,,2\n1374,WET AMD,\"**Wet AMD**, also known as **age-related macular degeneration (AMD)**, is a medical condition characterized by the presence of abnormal blood vessels in the macula. This condition is often associated with complement factor H gene mutations and can lead to vision loss.  It is a type of **CNV (choroidal neovascularization)** AMD that can be treated with technologies like Cas9. \n\",2\n4328,RETINAL PIGMENT EPITHELIUM (RPE),Part of the eye affected in dry AMD,2\n4327,DRY AMD,\"**DRY AMD (Age-Related Macular Degeneration)** is a type of age-related macular degeneration that does not lead to severe vision loss. \n\",2\n3533,29,\"The study involved **29** patients.  This number is also referred to as the number of eyes in the study. \n\",1\n4337,NEOVASCULAR ENDOTHELIAL CELLS,Cells involved in blood vessel formation,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n588,MNV,INTRAVITREAL INJECTION,MNV lesion area was measured before and after the loading phase of intravitreal injection,25\n3,CHOROIDAL NEOVASCULARIZATION,HUMAN CHORODIAL VASCULAR ENDOTHELIAL CELLS,Human choroidal vascular endothelial cells are a key component of the CNV model,24\n1516,HONOKIOL,CHOROIDAL NEOVASCULARIZATION,\"**Honokiol** is a compound that has been studied for its potential therapeutic effects on **choroidal neovascularization (CNV)**.  Research using mouse models has shown that Honokiol can reduce the thickness, length, and area of CNV lesions. This suggests that Honokiol may be a promising candidate for treating CNV-related conditions in humans. \n\",24\n2,MALAT1,CHOROIDAL NEOVASCULARIZATION,MALAT1 is a long non-coding RNA that regulates the progression of CNV,23\n1515,ARPE-19,CHOROIDAL NEOVASCULARIZATION,Cells were used to study the formation of choroidal neovascularization,23\n1520,CHOROIDAL NEOVASCULARIZATION,TRANSWELL AND TUBE FORMATION ASSAYS,Choroidal neovascularization is studied using transwell and tube formation assays,20\n1521,CHOROIDAL NEOVASCULARIZATION,CHROMATIN IMMUNOPRECIPITATION,Choroidal neovascularization is studied using chromatin immunoprecipitation,20\n1211,CHOROIDAL NEOVASCULARIZATION,LASER PHOTOCOAGULATION,CNV was induced by laser photocoagulation in a murine model,19\n1518,CHOROIDAL NEOVASCULARIZATION,HEMATOXYLIN AND EOSIN STAINING,Choroidal neovascularization is studied using hematoxylin and eosin staining,19\n1519,CHOROIDAL NEOVASCULARIZATION,LUCIFERASE ASSAY,Choroidal neovascularization is studied using luciferase assay,19\n1527,CHOROIDAL NEOVASCULARIZATION,FUNDUS FLUORESCEIN ANGEIOGRAPHY,Choroidal neovascularization leakage was reduced in the honokiol group as shown by fundus fluorescein angiography,19\n1528,CHOROIDAL NEOVASCULARIZATION,MECHANISM STUDIES,Mechanism studies have shown that honokiol exerts inhibitory effects on choroidal neov,19\n721,MACULAR DEGENERATION,AGE-RELATED MACULAR DEGENERATION,AMD is a disease of the macula and is related to age-related macular degeneration,12\n854,AGE-RELATED MACULAR DEGENERATION,POLYPOIDAL CHORODIAL VASCUOPATHY,\"AMD and PCV are related, with PCV being a distinct entity from AMD\",11\n661,PM-CNV,INTRAVITREAL INJECTION,PM-CNV can be treated with intravitreal injections,9\n1883,AGE-RELATED MACULAR DEGENERATION,EXUDATIVE AMD,Age-related macular degeneration is a type of exudative AMD,9\n652,1+PRN,3+PRN,The 3+PRN group was larger than the 1+PRN group,8\n654,3+PRN,CRT,The CRT was lower in the 3+PRN group than in the 1+PRN group,8\n655,CRT,BCVA,The CRT and BCVA were compared at month 3 and after 12 months,8\n1531,ARPE-19,HYPOXIA-INDUCIBLE FACTOR-1Α/VASCULAR ENDOTHELIAL GROWTH FACTOR AXIS,The ARPE-19 cells were used to study the effect of hypoxia on the vascular endothelial growth factor axis,8\n1532,ARPE-19,\"PROLIFERATION, MIGRATION, AND TUBE FORMATION\",\"The ARPE-19 cells were used to study the effect of honokiol on proliferation, migration, and tube formation\",8\n1936,ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR,INTRAVITREAL INJECTION,Method of administering anti-VEGF drugs,8\n656,CONBERCEPT,1+PRN,Conbercept is a medication used in the 1+PRN regimen for intravitreal injection,7\n718,NONEXUDATIVE MACULAR NEOVASCULARIZATION,MACULAR DEGENERATION,Nonexudative MNV is a condition that occurs in AMD,7\n1289,SULT2B1,MACULAR DEGENERATION,\"SULT2B1 is involved in inflammation and cholesterol metabolism, which are implicated in AMD\",7\n1522,HONOKIOL,IMMUNOFLOORESCENCE,Honokiol is used in immunofluorescence studies,7\n1523,HUMAN CHORODIAL VASCULAR ENDOTHELIAL CELLS,5-ETHYNYL-20-DEOXYURIDINE ASSAY,Used to study the effect of honokiol on human choroidal vascular endothelial cells,7\n1526,HONOKIOL,20MG/KG,The concentration of 20mg/kg showed better effects on choroidal neovascularization,7\n5,MALAT1,HCVECS,\"MALAT1 knockdown decreased HCVECs proliferation, migration, and tube formation in vitro\",6\n662,MALAT1,MICRORNA-15A/16,MALAT1 functions as a competing endogenous RNA for microRNA-15a/16 to regulate VEGFA expression,6\n1534,RETINAL PIGMENTED EPITHELIAL CELLS,HYPOXIA-INDUCIBLE FACTOR-1Α/VASCULAR ENDOTHELIAL GROWTH FACTOR AXIS,The retinal pigmented epithelial cells were used to study the effect of hypoxia on the vascular endothelial growth factor axis,6\n2338,MACULAR ATROPHY,54-YEAR-OLD WOMAN,The woman has a condition called macular atrophy,6\n2339,54-YEAR-OLD WOMAN,BRUCH MEMBRANE RUPTURE,The woman has a Bruch membrane rupture,6\n2342,54-YEAR-OLD WOMAN,ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR DRUG,The woman was treated with a drug to treat macular atrophy,6\n720,NONEXUDATIVE MACULAR NEOVASCULARIZATION,EXUDATIVE PROGRESSION,Nonexudative MNV in AMD that causes exudative progression,5\n946,MYOPIC CHOROIDAL NEOVASCULARIZATION,ANIMAL MODEL,mCNV is studied in animal models to develop treatments,5\n947,MYOPIC CHOROIDAL NEOVASCULARIZATION,VISION LOSS,mCNV is a cause of vision loss,5\n948,ANIMAL MODEL,GENE,Animal models can be used to study genes associated with mCNV,5\n949,ANIMAL MODEL,PATHWAY,Animal models can be used to study pathways associated with mCNV,5\n1510,BCVA,BASELINE,The baseline BCVA was measured before the follow-up period,5\n1511,BCVA,FOLLOW-UP,The BCVA was measured after 3 years,5\n1892,ENDOMETRAL-MESENCHYMAL TRANSITION,VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF),EndMT is involved in the regulation of angiogenesis by VEGF A,5\n2176,STABLE GROUP,LEION AREA,Stable group had a larger lesion area,5\n2177,STABLE GROUP,JUNCTION DENSITY,Stable group had higher junction density,5\n2178,UNSTABLE GROUP,LEION AREA,Unstable group had a larger lesion area,5\n76,RETINAL PIGMENTED EPITHELIUM (RPE),VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF),\"RPE cells produce VEGF, which is involved in blood vessel formation and development\",4\n719,NONEXUDATIVE MACULAR NEOVASCULARIZATION,TREATMENT-NAIVE NONEXUDATIVE MNV,Nonexudative MNV in AMD that has not been treated,4\n855,POLYPOIDAL CHORODIAL VASCUOPATHY,INDOCYANINE GREEN ANGIOLOGY,ICGA is used to diagnose PCV,4\n856,POLYPOIDAL CHORODIAL VASCUOPATHY,CONFLECT SCANNING LASER OPHTHALMOSCOPY,Confocal scanning laser ophthalmoscopy can be used to diagnose PCV,4\n950,GENE,PATHWAY,Genes and pathways are identified as potential targets for mCNV treatment,4\n1215,3K3A-APC,MOUSE MODEL,3K3A-APC is studied in a mouse model of CNV,4\n1290,SULT2B1,CHOROIDAL NECROPSY,SULT2B1 is specifically expressed in macrophages of the choroidal neovascularization lesions,4\n1513,20/50 SNELLEN EQUIVALENT,ACTIVE LESIONS,20 out of 29 eyes had active lesions at the end of the follow-up period,4\n1887,WET AMD,RETINAL PIGMENT EPITHELIUM (RPE),Wet AMD involves loss of RPE,4\n1888,DRY AMD,RETINAL PIGMENT EPITHELIUM (RPE),Dry AMD involves loss of RPE,4\n1514,29,ACTIVE LESIONS,20 out of 29 eyes had active lesions at the end of the follow-up period,3\n1891,NEOVASCULAR ENDOTHELIAL CELLS,ENDOMETRAL-MESENCHYMAL TRANSITION,EndMT is involved in renal fibrosis and angiogenesis,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_2b61c9b1a68e2b655d6ce9cc8fb6b5d10e04fb135cdcf18f80e3687c9b4fccf7_v2"}